Kristine Buchholtz

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial

Naim Alkhouri, Robert Herring, Heidi Kabler et al. · Journal of Hepatology · 2022 · 209 citations

Medicine, Pharmacology, Pharmacotherapy +16

Severity of Gentamicin's Nephrotoxic Effect on Patients with Infective Endocarditis: A Prospective Observational Cohort Study of 373 Patients

Kristine Buchholtz, Carsten T. Larsen, Christian Hassager et al. · Clinical Infectious Diseases · 2008 · 78 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Fast‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: Efficacy and safety from a randomized double‐blind trial

John B. Buse, Anders L. Carlson, Mitsuhisa Komatsu et al. · Diabetes Obesity and Metabolism · 2018 · 55 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

HERMES: Effects Of Ziltivekimab Versus Placebo On Morbidity And Mortality In Patients With Heart Failure With Mildly Reduced Or Preserved Ejection Fraction And Systemic Inflammation

Mark C. Petrie, Barry A. Borlaug, Kristine Buchholtz et al. · Journal of Cardiac Failure · 2024 · 51 citations

Medicine, Cardiology, Pharmacology +12